Article Details
Retrieved on: 2024-06-04 19:40:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Pfizer's KAT6 inhibitor, PF-07248144. Bodnar's assessment is influenced by the promising interim efficacy data from Pfizer's monotherapy in a ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here